ANGLE is a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) diagnostic solutions for use in research, drug development and clinical oncology using a simple blood sample. ANGLE's FDA cleared and patent protected circulating tumour cell (CTC) harvesting... Read More
ANGLE Company Contacts
Contacts
Country
United Kingdom
City
Surrey Research Park
Headquarters
Surrey Research Park, England
Profile
Founded
1994
Industry
Biotechnology Research
Size
51 - 200
Specialties
Liquid Biopsy, Circulating Tumor Cells, Biotechnology, Medical Device Manufacturer, microfluidics
Funding
Total Rounds
2
Last Round
Thu Jul 14 2022
Last Round Series
Post IPO equity
Last Round Raised
$ 23,864,113